Skip to main content
. 2019 Jan 4;49(4):339–346. doi: 10.1093/jjco/hyy189

Table 3.

ORR, RR, DpR and TTF in each ESMO guideline group

Group 1 Group 2 Group 3 P valuea
Response rate
Number of patients analyzed (N = 531) 156 216 159
Complete response 8 (5.1%) 4 (1.9%) 11 (6.9%) 0.03555
Partial response 91 (58.3%) 116 (53.7%) 83 (52.2%) 0.5188
Stable disease 33 (21.1%) 51 (23.6%) 33 (20.8%) 0.7807
Progressive disease 13 (8.3%) 29 (13.4%) 15 (9.4%) 0.2462
Not evaluable 6 (3.8%) 13 (6.0%) 12 (7.5%)
Unknown 5 (3.2%) 3 (1.4%) 5 (3.1%)
ORR (56.9%) 99 (63.5%) 120 (55.6%) 94 (59.1%) 0.3169
Disease control rate (80.9%) 132 (84.6%) 171 (79.2%) 127 (79.9%) 0.3744
Depth of response
Number of patients analyzed (N = 473) 145 189 139
Median 43.0% 43.3% 39.6% <0.6511
Interquartile range (20.6, 58.8) (11.9, 57.9) (15.0, 58.8)
Range (0, 100%) (0, 100%) (0, 100%)
Group 1 Group 2 Group 3 P valuea
Resection rate
Number of patients analyzed (N = 562) 165 224 173
Resection 94 (57.0%) 25 (11.2%) 20 (11.6%) <0.00001
Liver resection 66 (40.0%) 10 (4.5%) 11 (6.4%) <0.00001
R0 resection 68 (41.2%) 9 (4.0%) 7 (4.0%) <0.00001
Time to treatment failure
Number of patients analyzed (N = 562) 165 224 173
Median (day) 126 157.5 175 <0.019
Interquartile range (64.0, 250.0) (72.5, 269.0) (93.0, 322.0)
Range (day) (0, 1204) (0, 1022) (0, 771)

ORR, overall response rate; RR, resection rate; DpR, depth of response; TTF, time to treatment failure.

aOverall P value for the three groups was evaluated by Fisher’s exact test. When it was <0.05, post hoc pairwise comparisons by Fisher’s exact test were conducted, where multiplicity was adjusted by Holm’s method.